Analisadores hematológicos diferenciais de 3 partes vs. 5 partes vs. 7 partes: A matriz de decisão completa para mais de 50 cenários clínicos
Procurement teams spend thousands analyzing analyzer specifications, yet 73% still choose 5-part systems as the “safe middle ground.” But here’s what they don’t realize: 45% of the clinical scenarios they actually encounter demand 7-part capability. This critical mismatch between purchasing decisions and diagnostic requirements creates blind spots in patient care, missed early diagnoses, and suboptimal […]










